Equities
  • Price (EUR)50.87
  • Today's Change1.10 / 2.20%
  • Shares traded0.00
  • 1 Year change-14.73%
  • Beta--
Data delayed at least 15 minutes, as of Nov 21 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year Exact Sciences Corp grew revenues 19.93% from 2.08bn to 2.50bn. Additionally the company has reduced the cost of goods sold, selling, general and administrative expenses and debt expenses (all as percentages of sales). These changes narrowed profitability losses from -623.51m to -204.15m.
Gross margin72.96%
Net profit margin-7.95%
Operating margin-8.54%
Return on assets-3.25%
Return on equity-6.76%
Return on investment-3.58%
More ▼

Cash flow in USDView more

In 2023, Exact Sciences Corp increased its cash reserves by 151.11%, or 366.89m. Cash Flow from Financing totalled 159.77m or 6.39% of revenues. In addition the company generated 156.12m in cash from operations while cash from investing totalled 49.68m.
Cash flow per share0.01
Price/Cash flow per share5,387.82
Book value per share17.35
Tangible book value per share-5.52
More ▼

Balance sheet in USDView more

Exact Sciences Corp has a Debt to Total Capital ratio of 44.59%, a lower figure than the previous year's 74.37%.
Current ratio2.12
Quick ratio1.93
Total debt/total equity0.8047
Total debt/total capital0.4459
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.